Eledon Pharmaceuticals, Inc. Fair Value, Assets, Level 2 to Level 1 Transfers, Amount
Eledon Pharmaceuticals, Inc. (ELDN) had Fair Value, Assets, Level 2 to Level 1 Transfers, Amount of $0 as of 2021-12-31, per its 10-K filed 2022-03-24.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount · last filed 2022-03-24
- 2021-12-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2020-12-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2019-12-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2018-12-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-24 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-24 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-17 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-28 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-08 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 |
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |